U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 620

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr11:61793-10749516
GRCh38:
Chr11:61793-10727969
A-GAMMA3'E, ADM, ADM-DT, AKIP1, AMPD3, ANO9, AP2A2, APBB1, ARFIP2, ART1, ART5, ASCL2, ASCL3, B4GALNT4, BET1L, BGLT3, BRSK2, C11orf16, C11orf21, C11orf40, C11orf42, CAND1.11, CARS1, CARS1-AS1, CASC23, CAVIN3, CCKBR, CD151, CD81, CD81-AS1, CDHR5, CDKN1C, CEND1, CHID1, CHRNA10, CIMAP1A, CNGA4, CRACR2B, CTSD, CYB5R2, DCHS1, DEAF1, DENND2B, DENND2B-AS1, DENND5A, DNHD1, DRD4, DUSP8, EIF3F, EPS8L2, FAM99A, FAM99B, FHIP1B, GATD1, GATD1-DT, H19, H19-ICR, HBB, HBB-3'HS1, HBB-HS-107, HBB-HS-111, HBB-LCR, HBD, HBE1, HBG1, HBG2, HOTS, HPX, HRAS, HS-E1, IFITM1, IFITM10, IFITM2, IFITM3, IFITM5, IGF2, IGF2-AS, ILK, INS, INS-IGF2, IPO7, IRAG1, IRAG1-AS1, IRF7, KCNQ1, KCNQ1-AS1, KCNQ1DN, KCNQ1OT1, KRTAP5-1, KRTAP5-2, KRTAP5-3, KRTAP5-4, KRTAP5-5, KRTAP5-6, KRTAP5-AS1, LINC01001, LINC01150, LINC01219, LINC02688, LINC02708, LINC02709, LINC02749, LMNTD2, LMNTD2-AS1, LMO1, LOC101927708, LOC101928008, LOC105274310, LOC105369149, LOC105376526, LOC106099062, LOC106099063, LOC106099064, LOC106099065, LOC106783508, LOC106799843, LOC106865369, LOC107133510, LOC109623489, LOC109951029, LOC110006319, LOC110008579, LOC110011217, LOC110013311, LOC110121378, LOC110121453, LOC111718490, LOC112067719, LOC112067720, LOC112081391, LOC112081400, LOC112081404, LOC112081405, LOC112136080, LOC112136081, LOC112136092, LOC112136094, LOC113939920, LOC113939924, LOC113939927, LOC113939928, LOC114827852, LOC116216126, LOC116216127, LOC116216128, LOC116216129, LOC121392887, LOC121392888, LOC121392889, LOC121392890, LOC121832782, LOC121832783, LOC121832784, LOC121832785, LOC121832786, LOC124418409, LOC124418411, LOC124418412, LOC124418413, LOC124418414, LOC124418415, LOC124418416, LOC124418418, LOC124418419, LOC124418420, LOC124418421, LOC124418422, LOC124418423, LOC124418426, LOC124421482, LOC124421483, LOC124421484, LOC124421485, LOC124421486, LOC124902806, LOC126861108, LOC126861109, LOC126861110, LOC126861111, LOC126861112, LOC126861113, LOC126861114, LOC126861115, LOC126861116, LOC126861117, LOC126861118, LOC126861119, LOC126861120, LOC126861121, LOC126861122, LOC126861123, LOC126861124, LOC126861125, LOC126861126, LOC126861127, LOC126861128, LOC126861129, LOC126861130, LOC126861131, LOC126861132, LOC126861133, LOC126861134, LOC126861135, LOC126861136, LOC126861137, LOC126861138, LOC126861139, LOC143666, LOC283299, LOC644656, LRRC56, LSP1, LYVE1, MIR210, MIR210HG, MIR302E, MIR4298, MIR4485, MIR4686, MIR4687, MIR483, MIR5691, MIR6743, MIR6744, MIR675, MIR7847, MMP26, MOB2, MRGPRE, MRGPRG, MRGPRG-AS1, MRPL17, MRPL23, MRPL23-AS1, MTRNR2L8, MUC2, MUC5AC, MUC5B, MUC5B-AS1, MUC6, NAP1L4, NLRP10, NLRP14, NLRP6, NRIP3, NRIP3-DT, NUP98, OLFML1, OR10A2, OR10A3, OR10A4, OR10A5, OR10A6, OR2AG1, OR2AG2, OR2D2, OR2D3, OR51A2, OR51A4, OR51A7, OR51B2, OR51B4, OR51B5, OR51B6, OR51C1P, OR51D1, OR51E1, OR51E2, OR51F1, OR51F2, OR51G1, OR51G2, OR51I1, OR51I2, OR51J1, OR51L1, OR51M1, OR51Q1, OR51S1, OR51T1, OR51V1, OR52A1, OR52A5, OR52B2, OR52B4, OR52B6, OR52D1, OR52E1, OR52E2, OR52E4, OR52E5, OR52E6, OR52E8, OR52H1, OR52I1, OR52I2, OR52J3, OR52K1, OR52K2, OR52L1, OR52M1, OR52N1, OR52N2, OR52N4, OR52N5, OR52P1, OR52R1, OR52W1, OR56A1, OR56A3, OR56A4, OR56A5, OR56B1, OR56B2P, OR56B4, OR5P2, OR5P3, OR6A2, OSBPL5, OVCH2, PANO1, PGAP2, PGGHG, PHLDA2, PHRF1, PIDD1, PKP3, PNPLA2, POLR2L, PPFIBP2, PRADX, PRR33, PSMD13, PTDSS2, RASSF7, RBMXL2, RHOG, RIC3, RIC3-DT, RIC8A, RNF141, RNH1, RPL27A, RPLP2, RRM1, RRP8, SBF2, SBF2-AS1, SCGB1C1, SCT, SCUBE2, SIGIRR, SIRT3, SLC22A18, SLC22A18AS, SLC25A22, SMPD1, SNORA23, SNORA3A, SNORA3B, SNORA52, SNORA54, SNORD131, SSU72L1, SSU72L2, SSU72L3, SSU72L4, SSU72L5, STIM1, STIM1-AS1, STK33, SWAP70, SYT8, SYT9, SYT9-AS1, TAF10, TALDO1, TH, TIMM10B, TMEM41B, TMEM80, TMEM9B, TMEM9B-AS1, TNNI2, TNNT3, TOLLIP, TOLLIP-DT, TPP1, TRIM21, TRIM22, TRIM3, TRIM34, TRIM5, TRIM6, TRIM66, TRIM68, TRL-CAA5-1, TRPM5, TSPAN32, TSPAN4, TSSC4, TUB, TUB-AS1, UBQLN3, UBQLNL, WEE1, ZNF143, ZNF195, ZNF214, ZNF215
See casesPathogenic
(Apr 30, 2011)
no assertion criteria provided
2.
GRCh37:
Chr11:196855-2137415
GRCh38:
Chr11:196855-2116185
See casesPathogenic
(Aug 13, 2012)
no assertion criteria provided
3.
GRCh37:
Chr11:196855-5343104
GRCh38:
Chr11:196855-5321874
HBB, HBB-3'HS1, HBB-LCR, HBD, HBE1, HBG1, HBG2, HOTS, HRAS, HS-E1, IFITM1, IFITM10, IFITM2, IFITM3, IFITM5, IGF2, IGF2-AS, INS, INS-IGF2, IRF7, KCNQ1, KCNQ1-AS1, KCNQ1DN, KCNQ1OT1, KRTAP5-1, KRTAP5-2, KRTAP5-3, KRTAP5-4, KRTAP5-5, KRTAP5-6, KRTAP5-AS1, LINC01150, LINC01219, LINC02688, LINC02708, LINC02749, LMNTD2, LMNTD2-AS1, LOC101927708, LOC105274310, LOC105376526, LOC106099062, LOC106099063, LOC106099064, LOC106099065, LOC106783508, LOC106799843, LOC106865369, LOC107133510, LOC109623489, LOC109951029, LOC110006319, LOC110008579, LOC110011217, LOC110013311, LOC110121378, LOC111718490, LOC112067719, LOC112067720, LOC112081391, LOC113939920, LOC116216126, LOC116216127, LOC116216128, LOC121392887, LOC121392888, LOC121832782, LOC121832783, LOC124418409, LOC124418411, LOC124418412, LOC124418413, LOC124418414, LOC124418415, LOC124418416, LOC124418418, LOC124418419, LOC124418420, LOC124418421, LOC126861108, LOC126861109, LOC126861110, LOC126861111, LOC126861112, LOC126861113, LOC126861114, LOC126861115, LOC126861116, LOC126861117, LOC126861118, LOC143666, LRRC56, LSP1, MIR210, MIR210HG, MIR4298, MIR4686, MIR4687, MIR483, MIR6743, MIR6744, MIR675, MIR7847, MMP26, MOB2, MRGPRE, MRGPRG, MRGPRG-AS1, MRPL23, MRPL23-AS1, MUC2, MUC5AC, MUC5B, MUC5B-AS1, MUC6, NAP1L4, NLRP6, NUP98, ODF3, OR51A2, OR51A4, OR51A7, OR51B4, OR51C1P, OR51D1, OR51E1, OR51E2, OR51F1, OR51F2, OR51G1, OR51G2, OR51L1, OR51S1, OR51T1, OR51V1, OR52A1, OR52A5, OR52B4, OR52E1, OR52E2, OR52I1, OR52I2, OR52J3, OR52K1, OR52K2, OR52M1, OR52R1, OSBPL5, PANO1, PGAP2, PGGHG, PHLDA2, PHRF1, PIDD1, PKP3, PNPLA2, POLR2L, PRADX, PRR33, PSMD13, PTDSS2, RASSF7, RHOG, RIC8A, RNH1, RPLP2, RRM1, SCT, SIGIRR, SIRT3, SLC22A18, SLC22A18AS, SLC25A22, SNORA52, SNORA54, SNORD131, SSU72L1, SSU72L2, SSU72L3, SSU72L4, SSU72L5, STIM1, STIM1-AS1, SYT8, TALDO1, TH, TMEM80, TNNI2, TNNT3, TOLLIP, TOLLIP-DT, TRIM21, TRIM68, TRPM5, TSPAN32, TSPAN4, TSSC4, ZNF195, A-GAMMA3'E, ANO9, AP2A2, ART1, ART5, ASCL2, B4GALNT4, BET1L, BGLT3, BRSK2, C11orf21, C11orf40, CARS1, CARS1-AS1, CD151, CD81, CD81-AS1, CDHR5, CDKN1C, CEND1, CHID1, CHRNA10, CRACR2B, CTSD, DEAF1, DRD4, DUSP8, EPS8L2, FAM99A, FAM99B, GATD1, GATD1-DT, H19, H19-ICR
See casesPathogenic
(Aug 13, 2012)
no assertion criteria provided
4.
GRCh37:
Chr11:196966-3398307
GRCh38:
Chr11:196966-3377077
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
5.
GRCh37:
Chr11:196966-4456574
GRCh38:
Chr11:196966-4435344
ANO9, AP2A2, ART1, ART5, ASCL2, B4GALNT4, BET1L, BRSK2, C11orf21, CARS1, CARS1-AS1, CD151, CD81, CD81-AS1, CDHR5, CDKN1C, CEND1, CHID1, CHRNA10, CRACR2B, CTSD, DEAF1, DRD4, DUSP8, EPS8L2, FAM99A, FAM99B, GATD1, GATD1-DT, H19, H19-ICR, HOTS, HRAS, IFITM1, IFITM10, IFITM2, IFITM3, IFITM5, IGF2, IGF2-AS, INS, INS-IGF2, IRF7, KCNQ1, KCNQ1-AS1, KCNQ1DN, KCNQ1OT1, KRTAP5-1, KRTAP5-2, KRTAP5-3, KRTAP5-4, KRTAP5-5, KRTAP5-6, KRTAP5-AS1, LINC01150, LINC01219, LINC02688, LINC02708, LINC02749, LMNTD2, LMNTD2-AS1, LOC101927708, LOC105274310, LOC105376526, LOC106783508, LOC106799843, LOC106865369, LOC109623489, LOC110121378, LOC111718490, LOC112067719, LOC112067720, LOC112081391, LOC113939920, LOC116216126, LOC116216127, LOC121392887, LOC121392888, LOC121832782, LOC121832783, LOC124418409, LOC124418411, LOC124418412, LOC124418413, LOC124418414, LOC124418415, LOC124418416, LOC124418418, LOC124418419, LOC124418420, LOC124418421, LOC126861108, LOC126861109, LOC126861110, LOC126861111, LOC126861112, LOC126861113, LOC126861114, LOC126861115, LOC126861116, LOC143666, LRRC56, LSP1, MIR210, MIR210HG, MIR4298, MIR4686, MIR4687, MIR483, MIR6743, MIR6744, MIR675, MIR7847, MOB2, MRGPRE, MRGPRG, MRGPRG-AS1, MRPL23, MRPL23-AS1, MUC2, MUC5AC, MUC5B, MUC5B-AS1, MUC6, NAP1L4, NLRP6, NUP98, ODF3, OR52B4, OSBPL5, PANO1, PGAP2, PGGHG, PHLDA2, PHRF1, PIDD1, PKP3, PNPLA2, POLR2L, PRADX, PRR33, PSMD13, PTDSS2, RASSF7, RHOG, RIC8A, RNH1, RPLP2, RRM1, SCT, SIGIRR, SIRT3, SLC22A18, SLC22A18AS, SLC25A22, SNORA52, SNORA54, SNORD131, SSU72L1, SSU72L2, SSU72L3, SSU72L4, SSU72L5, STIM1, STIM1-AS1, SYT8, TALDO1, TH, TMEM80, TNNI2, TNNT3, TOLLIP, TOLLIP-DT, TRIM21, TRPM5, TSPAN32, TSPAN4, TSSC4, ZNF195
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
6.
GRCh37:
Chr11:218365-3398307
GRCh38:
Chr11:218365-3377077
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
7.
GRCh37:
Chr11:446754-18926289
GRCh38:
Chr11:446754-18904742
A-GAMMA3'E, ABCC8, ADM, ADM-DT, AKIP1, AMPD3, AP2A2, APBB1, ARFIP2, ART1, ART5, ASCL2, ASCL3, BGLT3, BMAL1, BRSK2, BTBD10, C11orf16, C11orf21, C11orf40, C11orf42, C11orf58, CALCA, CALCB, CAND1.11, CARS1, CARS1-AS1, CASC23, CAVIN3, CCKBR, CD151, CD81, CD81-AS1, CDHR5, CDKN1C, CEND1, CHID1, CHRNA10, CNGA4, COPB1, CRACR2B, CSNK2A3, CTR9, CTSD, CYB5R2, CYP2R1, DCHS1, DEAF1, DENND2B, DENND2B-AS1, DENND5A, DKK3, DNHD1, DRD4, DUSP8, EIF3F, EIF4G2, EPS8L2, FAM99A, FAM99B, FAR1, FHIP1B, GALNT18, GATD1, GATD1-DT, GTF2H1, H19, H19-ICR, HBB, HBB-3'HS1, HBB-HS-107, HBB-HS-111, HBB-LCR, HBD, HBE1, HBG1, HBG2, HOTS, HPS5, HPX, HRAS, HS-E1, IFITM10, IGF2, IGF2-AS, IGSF22, ILK, INS, INS-IGF2, INSC, IPO7, IRAG1, IRAG1-AS1, IRF7, KCNC1, KCNJ11, KCNQ1, KCNQ1-AS1, KCNQ1DN, KCNQ1OT1, KRTAP5-1, KRTAP5-2, KRTAP5-3, KRTAP5-4, KRTAP5-5, KRTAP5-6, KRTAP5-AS1, LDHA, LDHAL6A, LDHC, LINC00958, LINC01150, LINC01219, LINC02545, LINC02547, LINC02548, LINC02682, LINC02683, LINC02688, LINC02708, LINC02709, LINC02729, LINC02749, LINC02751, LINC02752, LMNTD2, LMNTD2-AS1, LMO1, LOC101927708, LOC101928008, LOC101928053, LOC105274310, LOC105369149, LOC105376526, LOC106099062, LOC106099063, LOC106099064, LOC106099065, LOC106736470, LOC106783508, LOC106799843, LOC106865369, LOC107133510, LOC107988023, LOC108254681, LOC108281125, LOC109623489, LOC109951029, LOC110006319, LOC110008579, LOC110011217, LOC110013311, LOC110120848, LOC110120922, LOC110120926, LOC110120947, LOC110121340, LOC110121343, LOC110121378, LOC110121434, LOC110121453, LOC110121471, LOC110121483, LOC111413037, LOC111718490, LOC111982890, LOC112042781, LOC112042782, LOC112067712, LOC112067713, LOC112067714, LOC112067715, LOC112067716, LOC112067719, LOC112067720, LOC112081391, LOC112081400, LOC112081404, LOC112081405, LOC112136080, LOC112136081, LOC112136092, LOC112136094, LOC113939920, LOC113939924, LOC113939927, LOC113939928, LOC114827852, LOC116216127, LOC116216128, LOC116216129, LOC121392887, LOC121392888, LOC121392889, LOC121392890, LOC121392891, LOC121392892, LOC121832782, LOC121832783, LOC121832784, LOC121832785, LOC121832786, LOC121832787, LOC121832788, LOC124418411, LOC124418412, LOC124418413, LOC124418414, LOC124418415, LOC124418416, LOC124418418, LOC124418419, LOC124418420, LOC124418421, LOC124418422, LOC124418423, LOC124418426, LOC124421482, LOC124421483, LOC124421484, LOC124421485, LOC124421486, LOC124421487, LOC124421488, LOC124421489, LOC124421490, LOC124421491, LOC124421492, LOC124421493, LOC124421494, LOC124421495, LOC124421496, LOC124421497, LOC124421498, LOC124421499, LOC124421500, LOC124421501, LOC124421502, LOC124421503, LOC124902806, LOC126861109, LOC126861110, LOC126861111, LOC126861112, LOC126861113, LOC126861114, LOC126861115, LOC126861116, LOC126861117, LOC126861118, LOC126861119, LOC126861120, LOC126861121, LOC126861122, LOC126861123, LOC126861124, LOC126861125, LOC126861126, LOC126861127, LOC126861128, LOC126861129, LOC126861130, LOC126861131, LOC126861132, LOC126861133, LOC126861134, LOC126861135, LOC126861136, LOC126861137, LOC126861138, LOC126861139, LOC126861140, LOC126861141, LOC126861142, LOC126861143, LOC126861144, LOC126861145, LOC126861146, LOC126861147, LOC126861148, LOC126861149, LOC126861150, LOC126861151, LOC126861152, LOC126861153, LOC126861154, LOC128772342, LOC128772343, LOC128772344, LOC128772345, LOC128772346, LOC143666, LOC283299, LOC644656, LRRC56, LSP1, LYVE1, MICAL2, MICALCL, MIR210, MIR210HG, MIR302E, MIR3159, MIR4298, MIR4299, MIR4485, MIR4686, MIR4687, MIR483, MIR5691, MIR6073, MIR6124, MIR6744, MIR675, MIR7847, MIR8070, MISFA, MMP26, MOB2, MRGPRE, MRGPRG, MRGPRG-AS1, MRGPRX3, MRGPRX4, MRPL17, MRPL23, MRPL23-AS1, MTRNR2L8, MUC2, MUC5AC, MUC5B, MUC5B-AS1, MUC6, MYOD1, NAP1L4, NCR3LG1, NLRP10, NLRP14, NRIP3, NRIP3-DT, NUCB2, NUP98, OLFML1, OR10A2, OR10A3, OR10A4, OR10A5, OR10A6, OR2AG1, OR2AG2, OR2D2, OR2D3, OR51A2, OR51A4, OR51A7, OR51B2, OR51B4, OR51B5, OR51B6, OR51C1P, OR51D1, OR51E1, OR51E2, OR51F1, OR51F2, OR51G1, OR51G2, OR51I1, OR51I2, OR51J1, OR51L1, OR51M1, OR51Q1, OR51S1, OR51T1, OR51V1, OR52A1, OR52A5, OR52B2, OR52B4, OR52B6, OR52D1, OR52E1, OR52E2, OR52E4, OR52E5, OR52E6, OR52E8, OR52H1, OR52I1, OR52I2, OR52J3, OR52K1, OR52K2, OR52L1, OR52M1, OR52N1, OR52N2, OR52N4, OR52N5, OR52P1, OR52R1, OR52W1, OR56A1, OR56A3, OR56A4, OR56A5, OR56B1, OR56B2P, OR56B4, OR5P2, OR5P3, OR6A2, OSBPL5, OTOG, OVCH2, PANO1, PARVA, PDE3B, PGAP2, PHLDA2, PHRF1, PIDD1, PIK3C2A, PLEKHA7, PNPLA2, POLR2L, PPFIBP2, PRADX, PRR33, PSMA1, PTDSS2, PTH, PTPN5, RASSF10, RASSF10-DT, RASSF7, RBMXL2, RHOG, RIC3, RIC3-DT, RNF141, RNH1, RPL27A, RPLP2, RPS13, RRAS2, RRM1, RRP8, SAA1, SAA2, SAA2-SAA4, SAA4, SAAL1, SBF2, SBF2-AS1, SCT, SCUBE2, SERGEF, SLC22A18, SLC22A18AS, SLC25A22, SMPD1, SNORA23, SNORA3A, SNORA3B, SNORA52, SNORA54, SNORD131, SNORD147, SNORD14A, SNORD14B, SNORD97, SOX6, SPON1, SPTY2D1, SSU72L1, SSU72L2, SSU72L3, SSU72L4, SSU72L5, STIM1, STIM1-AS1, STK33, SWAP70, SYT8, SYT9, SYT9-AS1, TAF10, TALDO1, TEAD1, TH, TIMM10B, TMEM41B, TMEM80, TMEM86A, TMEM9B, TMEM9B-AS1, TNNI2, TNNT3, TOLLIP, TOLLIP-DT, TPH1, TPP1, TRIM21, TRIM22, TRIM3, TRIM34, TRIM5, TRIM6, TRIM66, TRIM68, TRL-CAA5-1, TRPM5, TSG101, TSPAN32, TSPAN4, TSSC4, TUB, TUB-AS1, UBQLN3, UBQLNL, UEVLD, USH1C, USP47, WEE1, ZBED5, ZBED5-AS1, ZNF143, ZNF195, ZNF214, ZNF215
See casesPathogenic
(Apr 30, 2010)
no assertion criteria provided
8.
GRCh38:
Chr11:499700-5279697
C11orf40, CEND1, FAM99A, LINC01219, LOC105274310, LOC105376526, LOC106099062, LOC110011217, LOC110013311, LOC121832782, LOC121832783, LOC124418411, LOC124418412, LOC124418420, LOC124418421, LOC126861109, LOC126861118, MIR4686, MIR4687, MIR483, MRGPRG, OR51C1P, OR51D1, OR51T1, OR51V1, OR52I1, OR52I2, PNPLA2, POLR2L, SCT, TH, TRIM68, TRPM5, TSPAN32, TNNI2, TNNT3, TOLLIP, TOLLIP-DT, TRIM21, TSPAN4, TSSC4, ZNF195, SSU72L1, SSU72L2, SSU72L3, RNH1, RPLP2, RRM1, SSU72L4, SSU72L5, STIM1, STIM1-AS1, SYT8, TALDO1, TMEM80, OR52J3, OR52K1, OR52B4, OR52E1, OR52E2, OR52K2, OR52M1, OR52R1, PIDD1, PRADX, PRR33, OR51E1, MUC5AC, MUC5B, MUC5B-AS1, OR51E2, OR51F1, OR51F2, OR51G1, OR51G2, OR51L1, OR51S1, RASSF7, RHOG, OR52A1, MIR6744, MIR675, LSP1, MIR210, MIR210HG, MIR4298, MIR7847, MMP26, MOB2, MRGPRE, OR52A5, MRGPRG-AS1, MRPL23, LOC126861110, LOC126861111, LOC126861114, LOC126861115, MRPL23-AS1, MUC2, LOC124418415, LOC124418416, LOC124418418, LOC124418419, LOC124418413, LOC124418414, LOC126861112, LOC126861113, LOC126861116, LOC126861117, LOC143666, LOC106099063, LOC106099064, LOC106099065, LOC106783508, LOC106799843, LOC106865369, LOC107133510, LOC109623489, LOC109951029, LOC110006319, LOC110008579, LRRC56, LOC110121378, LOC111718490, LOC112067719, LOC112067720, LOC112081391, LOC113939920, FAM99B, GATD1, LOC116216127, LOC116216128, KCNQ1DN, LINC02688, LINC02708, LMNTD2-AS1, LMNTD2, LOC101927708, CARS1, LOC121392887, LOC121392888, CHID1, CHRNA10, DRD4, DUSP8, ART1, CARS1-AS1, CRACR2B, CTSD, EPS8L2, GATD1-DT, LINC02749, BRSK2, C11orf21, ART5, CD151, DEAF1, CD81, CD81-AS1, CDHR5, CDKN1C, HBE1, HBG1, ASCL2, BGLT3, HBG2, HOTS, AP2A2, A-GAMMA3'E, H19, H19-ICR, HBB, HBB-3'HS1, HBB-LCR, HBD, HRAS, HS-E1, IFITM10, IGF2, IGF2-AS, INS, INS-IGF2, IRF7, KCNQ1, KCNQ1-AS1, KCNQ1OT1, KRTAP5-1, KRTAP5-2, KRTAP5-3, KRTAP5-4, KRTAP5-5, KRTAP5-6, KRTAP5-AS1, LINC01150, MUC6, NAP1L4, NUP98, OR51A2, OR51A4, OR51A7, OSBPL5, PANO1, PGAP2, PHLDA2, PHRF1, SLC22A18, SLC22A18AS, SLC25A22, SNORA52, SNORA54, SNORD131
Thalassemia, gamma-delta-betaPathogenic
(Oct 1, 1989)
no assertion criteria provided
9.
GRCh37:
Chr11:532452
GRCh38:
Chr11:532452
HRAS, LRRC56not providedLikely benign
(Aug 15, 2019)
criteria provided, single submitter
10.
GRCh37:
Chr11:532524
GRCh38:
Chr11:532524
HRAS, LRRC56not specifiedLikely benign
(Feb 24, 2012)
criteria provided, single submitter
11.
GRCh37:
Chr11:532570
GRCh38:
Chr11:532570
HRAS, LRRC56not providedBenign
(Mar 3, 2015)
criteria provided, single submitter
12.
GRCh37:
Chr11:532573-534003
GRCh38:
Chr11:532573-534003
HRAS, LRRC56Costello syndromeUncertain significance
(Dec 20, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr11:532596
GRCh38:
Chr11:532596
HRAS, LRRC56not providedBenign
(Dec 13, 2019)
criteria provided, single submitter
14.
GRCh37:
Chr11:532602
GRCh38:
Chr11:532602
HRAS, LRRC56not providedBenign
(Dec 18, 2019)
criteria provided, single submitter
15.
GRCh37:
Chr11:532607
GRCh38:
Chr11:532607
HRAS, LRRC56not providedBenign
(Feb 23, 2020)
criteria provided, single submitter
16.
GRCh37:
Chr11:532611
GRCh38:
Chr11:532611
HRAS, LRRC56not specifiedBenign
(Mar 10, 2015)
criteria provided, single submitter
17.
GRCh37:
Chr11:532617
GRCh38:
Chr11:532617
HRAS, LRRC56not providedLikely benign
(May 23, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr11:532617
GRCh38:
Chr11:532617
HRAS, LRRC56not specifiedBenign
(May 18, 2012)
criteria provided, single submitter
19.
GRCh37:
Chr11:532626-534332
GRCh38:
Chr11:532626-534332
HRAS, LRRC56Costello syndromeUncertain significance
(Jul 1, 2019)
criteria provided, single submitter
20.
GRCh37:
Chr11:532631-532755
GRCh38:
Chr11:532631-532755
HRAS, LRRC56Costello syndromeUncertain significance
(Aug 31, 2016)
criteria provided, single submitter
21.
GRCh37:
Chr11:532631-534375
GRCh38:
Chr11:532631-534375
HRAS, LRRC56not specifiedUncertain significance
(Jul 31, 2014)
criteria provided, single submitter
22.
GRCh37:
Chr11:532635
GRCh38:
Chr11:532635
HRAS, LRRC56not specified, not providedBenign/Likely benign
(Jul 5, 2016)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr11:532638-532640
GRCh38:
Chr11:532638-532640
HRAS, LRRC56S110del, S189delCostello syndromeUncertain significance
(Jan 26, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr11:532639
GRCh38:
Chr11:532639
HRAS, LRRC56Costello syndromeLikely benign
(Aug 30, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr11:532639
GRCh38:
Chr11:532639
HRAS, LRRC56Costello syndromeLikely benign
(Jan 31, 2020)
criteria provided, single submitter
26.
GRCh37:
Chr11:532640
GRCh38:
Chr11:532640
HRAS, LRRC56S110F, S189FCostello syndromeUncertain significance
(Sep 1, 2021)
criteria provided, single submitter
27.
GRCh37:
Chr11:532641
GRCh38:
Chr11:532641
HRAS, LRRC56S189A, S110ACostello syndromeUncertain significance
(Aug 27, 2021)
criteria provided, single submitter
28.
GRCh37:
Chr11:532642
GRCh38:
Chr11:532642
HRAS, LRRC56Costello syndromeLikely benign
(Nov 17, 2021)
criteria provided, single submitter
29.
GRCh37:
Chr11:532646
GRCh38:
Chr11:532646
HRAS, LRRC56V108A, V187ACostello syndromeUncertain significance
(Aug 28, 2021)
criteria provided, single submitter
30.
GRCh37:
Chr11:532647
GRCh38:
Chr11:532647
HRAS, LRRC56V108M, V187MCostello syndromeUncertain significance
(Jul 22, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr11:532651
GRCh38:
Chr11:532651
HRAS, LRRC56Costello syndromeLikely benign
(Nov 14, 2021)
criteria provided, single submitter
32.
GRCh37:
Chr11:532653-532654
GRCh38:
Chr11:532653-532654
HRAS, LRRC56K185fs, K106fsCostello syndromeUncertain significance
(Aug 12, 2021)
criteria provided, single submitter
33.
GRCh37:
Chr11:532655
GRCh38:
Chr11:532655
HRAS, LRRC56C105S, C184SCostello syndromeUncertain significance
(Jul 26, 2021)
criteria provided, single submitter
34.
GRCh37:
Chr11:532655
GRCh38:
Chr11:532655
HRAS, LRRC56C105Y, C184YCostello syndromeUncertain significance
(Aug 16, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr11:532658
GRCh38:
Chr11:532658
HRAS, LRRC56S104N, S183NCostello syndromeUncertain significance
(Mar 27, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr11:532660
GRCh38:
Chr11:532660
HRAS, LRRC56M182I, M103ICostello syndromeUncertain significance
(Oct 8, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr11:532661
GRCh38:
Chr11:532661
HRAS, LRRC56M103T, M182TCostello syndromeUncertain significance
(Aug 30, 2021)
criteria provided, single submitter
38.
GRCh37:
Chr11:532662
GRCh38:
Chr11:532662
HRAS, LRRC56M103L, M182LCostello syndromeUncertain significance
(Aug 9, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr11:532662
GRCh38:
Chr11:532662
HRAS, LRRC56M182V, M103Vnot provided, Costello syndromeUncertain significance
(Sep 14, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr11:532663
GRCh38:
Chr11:532663
HRAS, LRRC56Costello syndromeUncertain significance
(Aug 30, 2021)
criteria provided, single submitter
41.
GRCh37:
Chr11:532664
GRCh38:
Chr11:532664
HRAS, LRRC56C102Y, C181YCostello syndromeUncertain significance
(Sep 29, 2021)
criteria provided, single submitter
42.
GRCh37:
Chr11:532666
GRCh38:
Chr11:532666
HRAS, LRRC56Costello syndromeLikely benign
(Aug 30, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr11:532666
GRCh38:
Chr11:532666
HRAS, LRRC56Costello syndromeLikely benign
(Apr 9, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr11:532667
GRCh38:
Chr11:532667
HRAS, LRRC56G101D, G180DCostello syndromeUncertain significance
(Aug 1, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr11:532668
GRCh38:
Chr11:532668
LRRC56, HRASG101S, G180SCostello syndrome, not providedUncertain significance
(Jun 22, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr11:532669
GRCh38:
Chr11:532669
HRAS, LRRC56not provided, Costello syndromeLikely benign
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr11:532670
GRCh38:
Chr11:532670
HRAS, LRRC56P100L, P179LCostello syndrome, not providedUncertain significance
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr11:532671
GRCh38:
Chr11:532671
HRAS, LRRC56P179S, P100SCardiovascular phenotype, not provided, Costello syndrome
Uncertain significance
(Sep 30, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr11:532671
GRCh38:
Chr11:532671
HRAS, LRRC56P100A, P179ACostello syndromeLikely benign
(Sep 3, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr11:532672
GRCh38:
Chr11:532672
HRAS, LRRC56Costello syndromeLikely benign
(Oct 11, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr11:532672
GRCh38:
Chr11:532672
HRAS, LRRC56not provided, Cardiovascular phenotype, Costello syndrome,
not specified
Likely benign
(Sep 14, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr11:532674
GRCh38:
Chr11:532674
HRAS, LRRC56G178R, G99RCostello syndromeUncertain significance
(Aug 24, 2021)
criteria provided, single submitter
53.
GRCh37:
Chr11:532675-532677
GRCh38:
Chr11:532675-532677
HRAS, LRRC56S98del, S177delCostello syndromeUncertain significance
(Jul 6, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr11:532675
GRCh38:
Chr11:532675
HRAS, LRRC56Costello syndromeLikely benign
(Aug 14, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr11:532676-532677
GRCh38:
Chr11:532676-532677
HRAS, LRRC56S98fs, S177fsCostello syndromeUncertain significance
(May 19, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr11:532676
GRCh38:
Chr11:532676
HRAS, LRRC56S177T, S98TCostello syndromeUncertain significance
(Jul 14, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr11:532676
GRCh38:
Chr11:532676
HRAS, LRRC56S98N, S177NCostello syndromeUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
58.
GRCh37:
Chr11:532685
GRCh38:
Chr11:532685
HRAS, LRRC56P174H, P95HNoonan syndrome and Noonan-related syndromeUncertain significance
(Dec 12, 2016)
criteria provided, single submitter
59.
GRCh37:
Chr11:532686
GRCh38:
Chr11:532686
HRAS, LRRC56P174A, P95ACostello syndromeUncertain significance
(Oct 3, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr11:532686
GRCh38:
Chr11:532686
HRAS, LRRC56P174S, P95SRASopathyBenign
(Apr 18, 2017)
reviewed by expert panel
FDA Recognized Database
61.
GRCh37:
Chr11:532687
GRCh38:
Chr11:532687
HRAS, LRRC56Costello syndromeLikely benign
(Nov 27, 2019)
criteria provided, single submitter
62.
GRCh37:
Chr11:532688
GRCh38:
Chr11:532688
HRAS, LRRC56P173R, P94RCostello syndromeLikely benign
(Aug 23, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr11:532688
GRCh38:
Chr11:532688
HRAS, LRRC56P173L, P94LIntellectual disability, Costello syndromeUncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr11:532689
GRCh38:
Chr11:532689
HRAS, LRRC56P173S, P94Snot provided, Costello syndromeUncertain significance
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr11:532690
GRCh38:
Chr11:532690
HRAS, LRRC56not specified, Costello syndromeLikely benign
(Aug 31, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr11:532691
GRCh38:
Chr11:532691
HRAS, LRRC56N172S, N93SCostello syndromeUncertain significance
(Jun 28, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr11:532695-532724
GRCh38:
Chr11:532695-532724
HRAS, LRRC56Costello syndromeUncertain significance
(Aug 4, 2021)
criteria provided, single submitter
68.
GRCh37:
Chr11:532696
GRCh38:
Chr11:532696
HRAS, LRRC56RASopathyLikely benign
(Apr 3, 2017)
reviewed by expert panel
FDA Recognized Database
69.
GRCh37:
Chr11:532698
GRCh38:
Chr11:532698
HRAS, LRRC56K170*, K91*Costello syndromeUncertain significance
(Jun 27, 2019)
reviewed by expert panel
FDA Recognized Database
70.
GRCh37:
Chr11:532700
GRCh38:
Chr11:532700
HRAS, LRRC56R169L, R90LCostello syndromeUncertain significance
(Aug 24, 2021)
criteria provided, single submitter
71.
GRCh37:
Chr11:532700
GRCh38:
Chr11:532700
HRAS, LRRC56R169Q, R90QCostello syndrome, Large congenital melanocytic nevus, Linear nevus sebaceous syndrome,
Malignant tumor of urinary bladder, Costello syndrome, Epidermal nevus,
Thyroid cancer, nonmedullary, 2, Hereditary cancer-predisposing syndrome, not provided
Uncertain significance
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr11:532701
GRCh38:
Chr11:532701
HRAS, LRRC56R169W, R90WCardiovascular phenotype, Costello syndrome, Large congenital melanocytic nevus,
Linear nevus sebaceous syndrome, Malignant tumor of urinary bladder, Costello syndrome,
Epidermal nevus, Thyroid cancer, nonmedullary, 2, not specified
Uncertain significance
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr11:532703
GRCh38:
Chr11:532703
HRAS, LRRC56L168P, L89PNoonan syndrome and Noonan-related syndrome, Costello syndromeUncertain significance
(Aug 24, 2021)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr11:532708
GRCh38:
Chr11:532708
HRAS, LRRC56H166Q, H87QCostello syndromeLikely benign
(Oct 23, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr11:532709
GRCh38:
Chr11:532709
HRAS, LRRC56H166R, H87RCostello syndromeUncertain significance
(Apr 1, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr11:532710
GRCh38:
Chr11:532710
LRRC56, HRASH166Y, H87YCostello syndromeUncertain significance
(Oct 1, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr11:532711
GRCh38:
Chr11:532711
HRAS, LRRC56Costello syndromeLikely benign
(Jun 29, 2021)
criteria provided, single submitter
78.
GRCh37:
Chr11:532714
GRCh38:
Chr11:532714
HRAS, LRRC56Costello syndromeLikely benign
(Aug 16, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr11:532715
GRCh38:
Chr11:532715
HRAS, LRRC56R164Q, R85QCostello syndrome, not providedUncertain significance
(Jul 1, 2022)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr11:532715
GRCh38:
Chr11:532715
HRAS, LRRC56R164P, R85PCostello syndrome, Malignant tumor of urinary bladder, Linear nevus sebaceous syndrome,
Costello syndrome, Thyroid cancer, nonmedullary, 2, Large congenital melanocytic nevus,
Epidermal nevus
Uncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr11:532716
GRCh38:
Chr11:532716
HRAS, LRRC56R164W, R85WCostello syndrome, Hereditary cancer-predisposing syndromeUncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr11:532717
GRCh38:
Chr11:532717
HRAS, LRRC56I163M, I84MCostello syndromeUncertain significance
(Mar 20, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr11:532717
GRCh38:
Chr11:532717
HRAS, LRRC56Costello syndromeLikely benign
(Feb 2, 2020)
criteria provided, single submitter
84.
GRCh37:
Chr11:532719
GRCh38:
Chr11:532719
LRRC56, HRASI163F, I84FCostello syndromeUncertain significance
(Sep 1, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr11:532720
GRCh38:
Chr11:532720
HRAS, LRRC56E162D, E83DCostello syndromeUncertain significance
(Feb 18, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr11:532722
GRCh38:
Chr11:532722
HRAS, LRRC56E162Q, E83QCostello syndromeUncertain significance
(Jul 22, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr11:532722
GRCh38:
Chr11:532722
HRAS, LRRC56E162K, E83Knot provided, Costello syndromeUncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr11:532723
GRCh38:
Chr11:532723
HRAS, LRRC56Costello syndromeLikely benign
(Mar 23, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr11:532724
GRCh38:
Chr11:532724
HRAS, LRRC56R161H, R82HCostello syndrome, not specifiedUncertain significance
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr11:532725
GRCh38:
Chr11:532725
HRAS, LRRC56R161G, R82GHereditary cancer-predisposing syndromeUncertain significance
(Nov 8, 2021)
criteria provided, single submitter
91.
GRCh37:
Chr11:532725
GRCh38:
Chr11:532725
HRAS, LRRC56R161C, R82CLinear nevus sebaceous syndrome, Large congenital melanocytic nevus, Malignant tumor of urinary bladder,
Costello syndrome, Thyroid cancer, nonmedullary, 2, Epidermal nevus,
not provided, Costello syndrome
Uncertain significance
(Feb 10, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr11:532726
GRCh38:
Chr11:532726
HRAS, LRRC56Costello syndromeLikely benign
(Feb 7, 2021)
criteria provided, single submitter
93.
GRCh37:
Chr11:532727
GRCh38:
Chr11:532727
HRAS, LRRC56V81G, V160GCostello syndromeUncertain significance
(Feb 20, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr11:532727
GRCh38:
Chr11:532727
HRAS, LRRC56V160A, V81ACostello syndromeUncertain significance
(Aug 26, 2021)
criteria provided, single submitter
95.
GRCh37:
Chr11:532729
GRCh38:
Chr11:532729
HRAS, LRRC56L159F, L80FCostello syndromeUncertain significance
(Apr 21, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr11:532729
GRCh38:
Chr11:532729
HRAS, LRRC56RASopathyBenign
(Apr 18, 2017)
reviewed by expert panel
FDA Recognized Database
97.
GRCh37:
Chr11:532730
GRCh38:
Chr11:532730
HRAS, LRRC56L159S, L80SCostello syndromeUncertain significance
(Sep 8, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr11:532732
GRCh38:
Chr11:532732
HRAS, LRRC56Costello syndromeLikely benign
(Oct 8, 2020)
criteria provided, single submitter
99.
GRCh37:
Chr11:532733
GRCh38:
Chr11:532733
HRAS, LRRC56T158R, T79RCostello syndromeUncertain significance
(Oct 29, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr11:532733
GRCh38:
Chr11:532733
HRAS, LRRC56T158M, T79MCostello syndromeUncertain significance
(May 14, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination